Varex Imaging Corp·4

Feb 9, 4:13 PM ET

TSINGOS CHRISTINE A 4

Research Summary

AI-generated summary

Updated

Varex (VREX) Director Christine Tsingos Receives 8,483 Shares

What Happened
Christine A. Tsingos, a director of Varex Imaging Corp (VREX), had 8,483 deferred stock units (DSUs) converted/exercised into 8,483 common shares on February 9, 2026. The Form 4 reports an acquisition via exercise/conversion (transaction code M) for 8,483 shares and a corresponding derivative disposition line showing $0.00 — i.e., no cash paid or received in the conversion. This was not an open-market purchase or a sale; it reflects delivery of vested equity compensation.

Key Details

  • Transaction date: February 9, 2026. Transaction code: M (exercise/conversion of derivative).
  • Shares acquired: 8,483 common shares; disposition of 8,483 derivative units reported at $0.00. Total dollar value not reported on the form.
  • Shares owned after transaction: not specified in the provided excerpt.
  • Footnotes: F1 — each Deferred Stock Unit converts one-for-one into common stock. F2 — these DSUs were granted Feb 9, 2023, vested Feb 8, 2024, and delivery occurred on the third anniversary (Feb 9, 2026).
  • Filing timeliness: reported on Form 4 with the same report date (Feb 9, 2026); no late filing indicated.

Context
This was a routine conversion/delivery of previously granted, vested deferred stock units as part of director compensation — not a market purchase or sale. For retail investors, such conversions reflect compensation being converted into common shares and do not by themselves indicate the insider is buying or selling stock for speculative reasons. Transaction code M simply denotes an exercise/conversion of a derivative (here, DSUs converting to common stock).

Loading document...